EUPHORIA Coordinator iThera Medical have released a new video to showcase the processes behind managing a multi-centre international clinical study to measure inflammation using their MSOT technologies. The video features Claudia Jendrewski who takes us through the planning stages of preparation for the EUPHORIA clinical study protocol and recruitment processes. Watch it here. https://vimeo.com/719784005 [...]
In a new video, iThera Medical CEO Christian Wiest and CCO Philipp Bell discuss their R & D strategy and primary business goals in relation to the EU-funded projects EUPHORIA and STARSTEM (www.starstem.eu, Related Project, grant number 761214). They describe the criteria and key performance indicators they use to forge and evaluate university partnerships: the organizational structures, [...]
Medical device company iThera Medical announces that the second site in Germany has been initiated for the ongoing clinical study in the EU-funded Horizon 2020 project EUPHORIA. The project aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). The €2.3 million [...]
The EUPHORIA study The EUPHORIA study is now open at the Universitätsklinikum Jena, Klinik für Innere Medizin IV in Jena, Germany. This is the second clinical study site running the EUPHORIA study in Germany and they are currently recruiting patients to take part. Two patients are already registered and scanned with the MSOT [...]
The EUPHORIA project aims at bringing optoacoustic imaging into the clinics. Early transition to an established data format is key for clinical imaging interconnectivity and therefore part of the transition to a commercial product. Recently, the project made a big step forward in a two-day workshop that was organised at the iThera Medical premises in Munich. Participants from Rayfos [...]
